RBGLY DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reckitt Benckiser Group PLC Investors with Losses in Excess of $100K to Secure Counsel Before Important August 4 Deadline in Securities Class Action – RBGLY

Core Viewpoint - Rosen Law Firm is reminding purchasers of Reckitt Benckiser Group PLC's American Depositary Shares (ADSs) of the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors [1][2]. Group 1: Class Action Details - The class action pertains to ADS purchases made between January 13, 2021, and July 28, 2024, with a lead plaintiff deadline set for August 4, 2025 [1]. - Investors who purchased Reckitt ADSs may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success and recognition in this field [3]. - The firm has achieved significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that Reckitt failed to inform investors about the increased risk of necrotizing enterocolitis (NEC) in preterm infants due to its cow's milk-based formula, Enfamil, which misled investors regarding the company's business prospects [4]. - The claims suggest that Reckitt's positive statements about its operations were materially false and misleading, leading to investor damages when the true information became public [4].